SCHEMBL3975615

SCHEMBL3975615

COC(=O)c1occ(-c2ccccc2)c1C(O[SiH](C)C)C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.36
SRC P12931 1/20 0.36
FGFR2 P21802 1/20 0.36
FGFR4 P22455 1/20 0.36
FGFR3 P22607 1/20 0.36
HTT P42858 1/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
NPC1 O15118 2/20 0.35
KDM4E B2RXH2 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.34
PRKCZ Q05513 1/20 0.34
EGFR P00533 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
GABRA1 P14867 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3977605 0.86 MAPT (0.33) ALDH1A1NPC1KDM4EMEN1KMT2A
SCHEMBL3977654 0.81 PTGS1 (0.37) FGFR1SRCFGFR2FGFR4FGFR3
SCHEMBL3977063 0.72 LMNA (0.45) FGFR1SRCFGFR2FGFR4FGFR3
SCHEMBL4279554 0.72 PDE4A (0.32)
SCHEMBL28962190 0.71 SLC6A4 (0.45) FGFR1SRCFGFR2FGFR4FGFR3
SCHEMBL3974640 0.70 HTT (0.42) FGFR1SRCFGFR2FGFR4FGFR3
SCHEMBL3977268 0.70 GAA (0.33) ALDH1A1HPGDTSHRKDM4ERAB9A
SCHEMBL3979178 0.69 L3MBTL1 (0.44) FGFR1SRCFGFR2FGFR4FGFR3
SCHEMBL3983743 0.68 HTT (0.40) FGFR1SRCFGFR2FGFR4FGFR3
SCHEMBL3978094 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 FGFR1 159/4885SRC 3518/4885FGFR2 1011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.